Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02625961
Title Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Merck Sharp & Dohme Corp.
Indications
Therapies
Age Groups: adult
Covered Countries USA | TUR | NLD | ITA | FRA | FIN | ESP | CAN | BRA | AUS

Facility Status City State Zip Country Details
Call for Information (Investigational Site 0083) RECRUITING Los Angeles California 90095 United States Details
Call for Information (Investigational Site 0021) RECRUITING Orange California 92868 United States Details
Call for Information (Investigational Site 0085) RECRUITING Chicago Illinois 60612 United States Details
Call for Information (Investigational Site 0084) RECRUITING Indianapolis Indiana 46202 United States Details
Call for Information (Investigational Site 0081) RECRUITING Wichita Kansas 67226 United States Details
Call for Information (Investigational Site 0023) RECRUITING Minneapolis Minnesota 55455 United States Details
Call for Information (Investigational Site 0002) RECRUITING Hackensack New Jersey 07601 United States Details
Call for Information (Investigational Site 0018) RECRUITING New Brunswick New Jersey 08903 United States Details
Call for Information (Investigational Site 0004) RECRUITING New York New York 10016 United States Details
Call for Information (Investigational Site 0072) RECRUITING Cincinnati Ohio 45212 United States Details
Call for Information (Investigational Site 0009) RECRUITING Cleveland Ohio 44106 United States Details
Call for Information (Investigational Site 0074) RECRUITING Bala-Cynwyd Pennsylvania 19004 United States Details
Call for Information (Investigational Site 0078) RECRUITING Myrtle Beach South Carolina 29572 United States Details
Call for Information (Investigational Site 0080) RECRUITING Houston Texas 77030 United States Details
MSD Australia RECRUITING North Ryde Australia Details
MSD Brasil RECRUITING Sao Paulo Brazil Details
Merck Canada RECRUITING Kirkland Quebec H9H 4M7 Canada Details
MSD Finland Oy RECRUITING Espoo Finland Details
MSD France RECRUITING Paris France Details
MSD Italia S.r.l. RECRUITING Rome Italy Details
Merck Sharp & Dohme BV RECRUITING Haarlem Netherlands Details
Call for Information (Investigational Site 2402) RECRUITING Ponce 00717 Puerto Rico Details
Call for Information (Investigational Site 2400) RECRUITING Rio Piedras 00935 Puerto Rico Details
Merck Sharp & Dohme (I.A.) Corp RECRUITING Singapore Singapore Details
Merck Sharp and Dohme de Espana S.A. RECRUITING Madrid Spain Details
Merck Sharp & Dohme Ilaclari Ltd. Sti RECRUITING Istanbul Turkey Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field